Savara Pharmaceuticals
SVRA
#6601
Rank
ยฃ0.43 B
Marketcap
ยฃ2.55
Share price
-1.54%
Change (1 day)
-32.47%
Change (1 year)

Savara Pharmaceuticals (SVRA) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : ยฃ31.41 Million

According to Savara Pharmaceuticals's latest financial reports the company's total liabilities are ยฃ31.41 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Savara Pharmaceuticals - Total liabilities on balance sheet (from 2002 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31ยฃ29.19 M10.37%
2022-12-31ยฃ26.44 M11.22%
2021-12-31ยฃ23.78 M-2.84%
2020-12-31ยฃ24.47 M-6.98%
2019-12-31ยฃ26.31 M-24.21%
2018-12-31ยฃ34.71 M16.37%
2017-12-31ยฃ29.83 M-43.2%
2016-12-31ยฃ52.52 M156.65%
2015-12-31ยฃ20.46 M169.06%
2014-12-31ยฃ7.6 M68.59%
2013-12-31ยฃ4.51 M40.79%
2012-12-31ยฃ3.2 M-1.91%
2011-12-31ยฃ3.26 M179.95%
2010-12-31ยฃ1.16 M-19.77%
2009-12-31ยฃ1.45 M-54.78%
2008-12-31ยฃ3.21 M82.2%
2007-12-31ยฃ1.76 M39.2%
2006-12-31ยฃ1.26 M-93.05%
2005-12-31ยฃ18.23 M2773.7%
2004-12-31ยฃ0.63 M596.3%
2003-12-31ยฃ0.09 M-85.13%
2002-12-31ยฃ0.61 M-3%
2001-12-31ยฃ0.63 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ9.67 M-69.20%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.67 B 2,060.45%๐Ÿ‡บ๐Ÿ‡ธ USA